| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |